⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

August 29, 2024PLoS ONEOpen Access

Reduced injection risk behavior with co-located hepatitis C treatment at a syringe service program: The accessible care model

Claire So Jeong Lee Pedro Mateu‐Gelabert Yesenia Aponte Melendez Chunki Fong Shashi N. Kapadia Melinda Smith Kristen Marks Benjamin Eckhardt

View Full Paper

Ask AI

Bookmark

Share

Abstract

The main mode of transmission of Hepatitis C in North America is through injection drug use. Availability of accessible care for people who inject drugs is crucial for achieving hepatitis C elimination.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lee et al. (2024) studied this question.

synapsesocial.com/papers/68e5a6ecb6db643587541187 https://doi.org/10.1371/journal.pone.0308102

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Accessible Hepatitis C Care for People Who Inject DrugsRCT · 2022 · 74 citations
2Barriers to Hepatitis C Treatment and Interest in Telemedicine-Based Care Among Clients of a Syringe Access Program2024 · 5 citations
3Getting to the Point: A Community-Designed, Low-Barrier Hepatitis C Testing and Treatment Program for People Who Inject Drugs in Rural America2025
4Potential impact of curative and preventive interventions toward hepatitis C elimination in people who inject drugs–A network modeling study2024 · 7 citations
5Combination interventions for Hepatitis C and Cirrhosis reduction among people who inject drugs: An agent-based, networked population simulation experimentCohort Study · 2018 · 25 citations